Zimmer Biomet Holdings Overview
Zimmer Biomet Holdings (ZBH) has a P/E ratio of 24.45, below the Healthcare sector average of 26.85.
Get informed when a big investor buys or sells
+ Follow24.45
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Zimmer Biomet Holdings's p/e ratio stands at 24.45. That is below the Healthcare sector average of 26.85. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Zimmer Biomet Holdings sits lower the Healthcare benchmark (26.85) with a P/E ratio of 24.45. That is roughly 8.9% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 24.45 is attractive depends on Zimmer Biomet Holdings's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Zimmer Biomet Holdings's P/E ratio evolved across reporting periods, while the comparison chart places ZBH next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, P/E ratio is commonly used to spot outliers. Zimmer Biomet Holdings's reading of 24.45 (sector avg 26.85) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
